Włóknienie zaotrzewnowe – przegląd literatury  oraz doświadczenia własne

Włóknienie zaotrzewnowe jest rzadkim schorzeniem o niejasnej patogenezie. Charakteryzuje się obecnością włóknisto-zapalnej masy, zwykle otaczającej aortę brzuszną i tętnice biodrowe. Wczesne rozpoznanie i właściwe leczenie na ogół pozwala uniknąć ciężkich powikłań. Artykuł podsumowuje aktualną wiedzę dotyczącą włóknienia zaotrzewnowego. Zaproponowano również algorytm leczenia oparty na dostępnej literaturze oraz doświadczeniach własnych.

REFERENCJE (46)

Koep L, Zuidema GD. The clinical significance of retroperitoneal fibrosis. Surgery 1977; 81: 250-257. .

Google Scholar

ter Maaten JC, Smith AJ, Gans RO. Idiopathic retroperitoneal fibrosis: idiopathic or secondary to atherosclerosis? Neth J Med 2000; 56: 35-37. .

Google Scholar

Parums DV. The spectrum of chronic periaortitis. Histopathology 1990; 16: 423-431. .

Google Scholar

Vaglio A, Salvarani C, Buzio C. Retroperitoneal fibrosis. Lancet 2006; 367: 241-251. .

Google Scholar

Uibu T, Oksa P, Auvinen A, et al. Asbestos exposure as a risk factor for retroperitoneal fibrosis. Lancet 2004; 363: 1422-1426. .

Google Scholar

Meier P, Gilabert C, Burnier M, Blanc E. La fibrose retropéritonéale, une maladie inflammatoire méconnue. Observations clinique et revue de la littérature. Nephrologie 2003; 24: 173-180. .

Google Scholar

van Bommel EF. Retroperitoneal fibrosis. Neth J Med 2002; 60: 231-242. .

Google Scholar

Baker LR, Mallinson WJ, Gregory MC, et al. Idiopathic retroperitoneal fibrosis. A retrospective analysis of 60 cases. Br J Urol 1987; 60: 497-503. .

Google Scholar

Parums DV, Brown DL, Mitchinson MJ. Serum antibodies to oxidized low-density lipoproteins and ceroid in chronic periaortitis. Arch Pathol Lab Med 1990; 114: 383-387. .

Google Scholar

10.

Gilkeson GS, Allen NB. Retroperitoneal fibrosis. A true connective tissue disease. Rheum Dis Clin North Am 1996; 22: 23-38. .

Google Scholar

11.

Vaglio A, Corradi D, Manenti L, et al. Evidence of autoimmunity in chronic periaortitis: a prospective study. Am J Med 2003; 114: 454-462. .

Google Scholar

12.

Martorana D, Vaglio A, Greco P, et al. Chronic periaortitis and HLA-DRB1*03: another clue to an autoimmune origin. Arthritis Rheum 2006; 55: 126-130. .

Google Scholar

13.

Mitchinson MJ. Aortic disease in idiopathic retroperitoneal and mediastinal fibrosis. J Clin Pathol 1972; 25: 287-293. .

Google Scholar

14.

Vaglio A, Greco P, Corradi D, et al. Autoimmune aspects of chronic periaortitis. Autoimmun Rev 2006; 5: 458-464. .

Google Scholar

15.

Agarwal P, Fahn S, Frucht SJ. Diagnosis and management of pergolid-induced fibrosis. Mov Disord 2004; 19: 699-704. .

Google Scholar

16.

Ahmad S. Methyldopa and retroperitoneal fibrosis. Am Heart J 1983; 105: 1037-1038. .

Google Scholar

17.

Waters VV. Hydralazine, hydrochlorothiazide and ampicillin associated with retroperitoneal fibrosis: case report. J Urol 1989; 141: 936-937. .

Google Scholar

18.

Demko TM, Diamond JR, Groff J. Obstructive nephropathy as a result of retroperitoneal fibrosis: a review of its pathogenesis and associations. J Am Soc Nephrol 1997; 8: 684-688. .

Google Scholar

19.

Thomas MH, Chisholm GD. Retroperitoneal fibrosis associated with malignant disease. Br J Cancer 1973; 28: 453-458. .

Google Scholar

20.

Seth A, Ansari MS, Trikha V, Mittal R. Retroperitoneal fibrosis: a rare complication of Pott’s disease. J Urol 2001; 166: 622-623. .

Google Scholar

21.

Moul JW. Retroperitoneal fibrosis following radiotherapy for stage I testicular seminoma. J Urol 1992; 147: 124-126. .

Google Scholar

22.

Wilson MC, Berry AR, McNair TJ, Thomson JW. Obstructive uropathy after pan-proctocolectomy for ulcerative colitis. Gut 1980; 21: 808-809. .

Google Scholar

23.

Jois RN, Gaffney K, Marshall T, Scott DG. Chronic periaortitis. Rheumatology (Oxford) 2004; 43: 1441-1446. .

Google Scholar

24.

Kottra JJ, Dunnick NR. Retroperitoneal fibrosis. Radiol Clin North Am 1996; 34: 1259-1275. .

Google Scholar

25.

Warnatz K, Keskin AG, Uhl M, et al. Immunosuppressive treatment of chronic periaortitis: a retrospective study of 20 patients with chronic periaortitis and a review of the literature. Ann Rheum Dis 2005; 64: 828-833. .

Google Scholar

26.

Yamada H, Komatsu R, Nagae H, et al. Idiopathic retroperitoneal fibrosis with duodenal obstruction successfully treated with corticosteroids. Intern Med 1998; 37: 592-598. .

Google Scholar

27.

Vaglio A, Manetti L, Allegri L, et al. ANCA-positive periaortic vasculitis: does it fall within the spectrum of vasculitis? J Intern Med 2002; 251: 268-271. .

Google Scholar

28.

Mulligan SA, Holley HC, Koehler RE, et al. CT and MRI imaging in the evaluation of retroperitoneal fibrosis. J Comput Assist Tomogr 1989; 13: 277-281. .

Google Scholar

29.

Chander S, Ergun EL, Chugani HT, et al. High 2-deoxy-2-[18F]-fluoro-D-glucose accumulation in a case of retroperitoneal fibrosis following resection of carcinoid tumor. Mol Imaging Biol 2002; 4: 363-368. .

Google Scholar

30.

Salvarani C, Pipitone N, Versari A, et al. Positron emission tomography (PET): evaluation of chronic periaortitis. Arthritis Rheum 2005; 53: 298-303. .

Google Scholar

31.

Vaglio A, Versari A, Fraternali A, et al. 18F-fluorodeoxyglucose positron emission tomography in the diagnosis and follow-up of idiopathic retroperitoneal fibrosis. Arthritis Rheum 2005; 53: 122-125. .

Google Scholar

32.

Vaglio A, Greco P, Versari A, et al. Post-treatment residual tissue in idiopathic retroperitoneal fibrosis: active residual disease or silent “scar”? A study using 18F-fluorodeoxyglucose positron emission tomography. Clin Exp Rheumatol 2005; 23: 231-234. .

Google Scholar

33.

Wagenknecht LV, Hardy JC. Value of various treatments for retroperitoneal fibrosis. Eur Urol 1981; 7: 193-200. .

Google Scholar

34.

Ilie CP, Pemberton RJ, Tolley DA. Idiopathic retroperitoneal fibrosis: the case for nonsurgical treatment. BJU Int 2006; 98: 137-140. .

Google Scholar

35.

Maillart E, Laueriére L, Kassis S, et al. Peut-on proposer une prise en charge de la fibrose rétropéritonéale idiopathique validée par les données de la literature. Rev Med Interne 2006; 27: 854-857. .

Google Scholar

36.

Heidenreich A, Derakhshani P, Neubauer S, Krug B. Treatment outcomes in primary and secondary retroperitoneal fibrosis. Urologe A 2000; 39: 141-148. .

Google Scholar

37.

Harreby M, Bilde T, Helin P, et al. Retroperitoneal fibrosis treated with methylprednisolone pulse and disease-modifying antirheumatic drugs. Scand J Urol Nephrol 1994; 28: 237-242. .

Google Scholar

38.

Marcolongo R, Tavolini IM, Laveder F, et al. Immunosuppressive therapy for idiopathic retroperitoneal fibrosis: a retrospective analysis of 26 cases. Am J Med 2004; 116: 194-197. .

Google Scholar

39.

Scavalli AS, Spadaro A, Riccieri V, et al. Long-term follow-up of low-dose methotrexate therapy in one case of idiopathic retroperitoneal fibrosis. Clin Rheumatol 1995; 14: 481-484. .

Google Scholar

40.

Marzano A, Trapani A, Leone N, et al. Treatment of idiopathic retroperitoneal fibrosis using cyclosporin. Ann Rheum Dis 2001; 60: 427-428. .

Google Scholar

41.

Grotz W, von Zedtwitz I, Andre M, Schollmeyer P. Treatment of retroperitoneal fibrosis by mycophenolate mofetil and corticosteroids. Lancet 1998; 352: 1195. .

Google Scholar

42.

Tönshoff B. The current status of mycophenolate mofetil in pediatric renal transplantation. Pediatr Transplant 1999; 3: 5-9. .

Google Scholar

43.

Fry AC, Singh S, Gunda SS, et al. Successful use of steroids and ureteric stents in 24 patients with idiopathic retroperitoneal fibrosis: a retrospective study. Nephron Clin Pract 2008; 108: c213-c220. .

Google Scholar

44.

Loffeld RJ, van Weel TF. Tamoxifen for retroperitoneal fibrosis. Lancet 1993; 341: 382. .

Google Scholar

45.

van Bommel EF, Hendriksz TR, Huiskes AW, Zeegers AG. Brief communication: tamoxifen therapy for nonmalignant retroperitoneal fibrosis. Ann Intern Med 2006; 144: 101-106. .

Google Scholar

46.

Tralce L, Antonelli A, Dotti P, Cunico SC. Epidemiology, clinical features and treatment of idiopathic retroperitoneal fibrosis: our experience. Arch Ital Urol Androl 2004; 76: 135-139.

Google Scholar

Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.

Wyślij swój artykuł

Archiwum

Dla autorów

Udostępnij

Wyślij mailem

ARTYKUŁ POWIĄZANY

Artykuł przeglądowy
Praktyczne aspekty leczenia układowych zapaleń naczyń

Artykuł oryginalny
Prospektywna ocena dożylnych infuzji cyklofosfamidu w postępującym włóknieniu płuc w przebiegu układowych chorób tkanki łącznej – 12-miesięczna faza obserwacji

Krwotoczne zapalenie jelita grubego jako powikłanie leczenia cyklofosfamidem

Remisja w toczniowym zapaleniu nerek – opis trzech przypadków

Indeksy

Indeks słów kluczowych

Indeks dziedzin

Indeks autorów

eISSN:	2084-9834
ISSN:	0034-6233